Panagora Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$414K Sell
20,334
-119
-0.6% -$2.42K ﹤0.01% 846
2025
Q1
$371K Sell
20,453
-95,180
-82% -$1.73M ﹤0.01% 884
2024
Q4
$2.92M Sell
115,633
-1,041
-0.9% -$26.3K 0.01% 440
2024
Q3
$3.97M Sell
116,674
-1,673
-1% -$56.9K 0.02% 387
2024
Q2
$4.38M Buy
+118,347
New +$4.38M 0.02% 336
2021
Q3
Sell
-1,150
Closed -$38K 1841
2021
Q2
$38K Sell
1,150
-343
-23% -$11.3K ﹤0.01% 2099
2021
Q1
$31K Hold
1,493
﹤0.01% 2255
2020
Q4
$26K Sell
1,493
-281
-16% -$4.89K ﹤0.01% 2153
2020
Q3
$26K Hold
1,774
﹤0.01% 2144
2020
Q2
$23K Hold
1,774
﹤0.01% 2113
2020
Q1
$3K Hold
1,774
﹤0.01% 2342
2019
Q4
$4K Hold
1,774
﹤0.01% 2274
2019
Q3
$4K Buy
1,774
+101
+6% +$228 ﹤0.01% 2309
2019
Q2
$4K Sell
1,673
-5,017
-75% -$12K ﹤0.01% 2484
2019
Q1
$33K Hold
6,690
﹤0.01% 2146
2018
Q4
$20K Buy
6,690
+2,044
+44% +$6.11K ﹤0.01% 2218
2018
Q3
$31K Buy
4,646
+4,184
+906% +$27.9K ﹤0.01% 2134
2018
Q2
$3K Sell
462
-95,094
-100% -$617K ﹤0.01% 2326
2018
Q1
$3.34M Buy
95,556
+29,959
+46% +$1.05M 0.01% 679
2017
Q4
$2.79M Buy
+65,597
New +$2.79M 0.01% 739
2015
Q3
Sell
-259
Closed -$98K 2330
2015
Q2
$98K Sell
259
-310
-54% -$117K ﹤0.01% 1951
2015
Q1
$238K Sell
569
-1,230
-68% -$514K ﹤0.01% 1609
2014
Q4
$492K Buy
1,799
+1,673
+1,328% +$458K ﹤0.01% 1289
2014
Q3
$24K Sell
126
-46
-27% -$8.76K ﹤0.01% 2132
2014
Q2
$42K Sell
172
-634
-79% -$155K ﹤0.01% 2129
2014
Q1
$214K Buy
806
+760
+1,652% +$202K ﹤0.01% 1712
2013
Q4
$17K Buy
+46
New +$17K ﹤0.01% 2107